Open Access

VIEWPOINT

SARS-CoV-2 induced myocarditis: Current knowledge about its molecular and pathophysiological mechanisms

DOMENICO MARIA CARRETTA^1,§, MARINA DI DOMENICO^2,§, ROBERTO LOVERO³, ROBERTO ARRIGONI⁴, ANGELIKA ELZBIETA WEGIERSKA⁵, MARIAROSARIA BOCCELLINO^2,*, ANDREA BALLINI^2,6,*, IOANNIS ALEXANDROS CHARITOS^7,#, LUIGI SANTACROCE^5,#

1 AOU Policlinico Consorziale di Bari-Ospedale Giovanni XXIII, Cardiology Unit, Policlinico University Hospital of Bari, Bari, 70124, Italy
2 Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Naples, 80138, Italy
3 AOU Policlinico Consorziale di Bari-Ospedale Giovanni XXIII, Clinical Pathology Unit, Policlinico University Hospital of Bari, Bari, 70124, Italy
4 CNR Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), Bari, 70125, Italy
5 Department Interdisciplinary of Medicine, University of Bari “Aldo Moro”, Bari, 70124, Italy
6 School of Medicine, University of Bari “Aldo Moro”, Bari, 70124, Italy
7 Department of Emergency and Urgency, National Poisoning Centre, Riuniti University Hospital of Foggia, Foggia, 71122, Italy

* Corresponding Authors: Andrea Ballini, ; Mariarosaria Boccellino,
§ Contributed equally as co-first authors
# These authors contributed equally to this work